Literature DB >> 7631963

Theoretical analysis of cerebral venous blood hemoglobin oxygen saturation as an index of cerebral oxygenation during hypothermic cardiopulmonary bypass. A counterproposal to the "luxury perfusion" hypothesis.

F Dexter1, B J Hindman.   

Abstract

BACKGROUND: Jugular venous catheters and near-infrared spectroscopy can measure cerebral venous blood hemoglobin oxygen saturation (SvO2). We used computer simulation to characterize the relation between Sv02 and cerebral metabolic rate for oxygen (CMR02) during hypothermic cardiopulmonary bypass (CPB).
METHODS: We developed a theoretical model of cerebral oxygen consumption and blood-brain oxygen transfer. Our model included the temperature dependence of blood and brain oxygen solubility; the temperature, age, and acid-base dependence of hemoglobin oxygen dissociation; and the temperature and age dependence of CMRO2. We simulated cerebral blood flow reductions that decreased Sv02 and CMR02.
RESULTS: Our model predicts the relation between CMR02 and Sv02 to be dependent on temperature, because of a shift of the oxygen partial pressure at which hemoglobin oxygen saturation equals 0.50. For example, during normothermic CPB, Sv02 can decrease to 30% before CMR02 will decrease to less than 90% of normal. In contrast, for alpha-stat management of infants at 17 degrees C, Sv02 must be maintained at greater than 95% to maintain CMR02 at greater than 90% of its temperature appropriate value.
CONCLUSIONS: High Sv02 observed during hypothermic CPB may indicate impaired oxygen transfer from hemoglobin to brain, not "luxury perfusion." The relation between Sv02 and CMR02 depends dramatically on the temperature of the patient. Sv02 per se may not be reliable index of normal CMR02 during hypothermic CPB.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631963     DOI: 10.1097/00000542-199508000-00021

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Relationship of intraoperative cerebral oxygen saturation to neurodevelopmental outcome and brain magnetic resonance imaging at 1 year of age in infants undergoing biventricular repair.

Authors:  Barry D Kussman; David Wypij; Peter C Laussen; Janet S Soul; David C Bellinger; James A DiNardo; Richard Robertson; Frank A Pigula; Richard A Jonas; Jane W Newburger
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

Review 2.  Cooperativity Principles in Self-Assembled Nanomedicine.

Authors:  Yang Li; Yiguang Wang; Gang Huang; Jinming Gao
Journal:  Chem Rev       Date:  2018-04-25       Impact factor: 60.622

3.  Proton magnetic resonance spectroscopy assessment of neonatal brain metabolism during cardiopulmonary bypass surgery.

Authors:  Daniel M Spielman; Meng Gu; Ralph E Hurd; R Kirk Riemer; Kenichi Okamura; Frank L Hanley
Journal:  NMR Biomed       Date:  2022-05-18       Impact factor: 4.478

4.  Hemodilution with liposome-encapsulated low-oxygen-affinity hemoglobin does not attenuate hypothermic cerebral ischemia in rats.

Authors:  Teiji Oda; Tetsuhiro Kimura; Yoshitaka Ogata; Yutaka Fujise
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.385

5.  Non-invasive Assessment of Cerebral Blood Flow and Oxygen Metabolism in Neonates during Hypothermic Cardiopulmonary Bypass: Feasibility and Clinical Implications.

Authors:  Silvina L Ferradal; Koichi Yuki; Rutvi Vyas; Christopher G Ha; Francesca Yi; Christian Stopp; David Wypij; Henry H Cheng; Jane W Newburger; Aditya K Kaza; Maria A Franceschini; Barry D Kussman; P Ellen Grant
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

6.  Effective method of monitoring cerebral tissue oxygen saturation in cardiac surgery patients by combined use of tNIRS-1 and bispectral index.

Authors:  A Sugiura; K Torii; H Tsutsumi; T Someya; D Yasuoka; K Nishikiori; D Kitahara; H Kakinuma
Journal:  Sci Rep       Date:  2021-12-16       Impact factor: 4.379

7.  Rationale for Implementation of Warm Cardiac Surgery in Pediatrics.

Authors:  Yves Durandy
Journal:  Front Pediatr       Date:  2016-05-06       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.